Market Neuron Logo
⚠ Disclaimer: This report is generated using AI tools and is for informational purposes only. It does not constitute investment advice. Please consult a registered financial advisor before making any investment decisions.

TORNTPHARM - Technical Analysis

Last Updated Time : 02 Aug 25, 12:58 am

Back to Technical List

📊 Technical Analysis for TORNTPHARM (Torrent Pharmaceuticals Ltd.)

⭐ Technical Rating

4.6 (Strong technicals driven by bullish momentum, breakout structure, and volume surge)

📉 Chart Patterns & Trend Status

Trend Status: TORNTPHARM is in a strong uptrend, trading near its 52-week high.

Pattern Observed: Ascending triangle breakout with price surging past resistance.

Candlestick Signals: Recent Bullish Marubozu and Gap-Up Candle suggest aggressive buying.

📈 Moving Averages

Indicator Value (₹) Signal

50 DMA 3,369 Price above – Bullish

200 DMA 3,219 Price above – Bullish

20 EMA ~3,740 Price above – Bullish

Price is above all major moving averages, confirming a strong bullish trend.

📊 Momentum Indicators

Indicator Value Interpretation

RSI 79.4 Overbought – strong momentum, but caution for pullback

MACD 97.6 Bullish crossover – strong upward momentum

MFI ~78.5 Near overbought, strong accumulation

CCI ~185 Very strong uptrend confirmation

📉 Bollinger Bands & Volume

Price riding upper Bollinger Band, indicating momentum continuation.

Volume more than 2x average, confirming breakout strength.

📌 Support & Resistance Zones

Level Price (₹)

Support 1 3,740

Support 2 3,685

Resistance 1 3,785

Resistance 2 3,820

Resistance 3 3,875

Trendline resistance near ₹3,820–₹3,875.

Support holding around ₹3,685–₹3,740.

🎯 Entry & Exit Zones

Entry Zone: ₹3,685–₹3,740 (on minor pullback with volume support)

Exit Zone: ₹3,820–₹3,875 (short-term resistance zone)

Stop Loss: ₹3,660 (below recent breakout level)

🧭 Summary

TORNTPHARM is in a strong bullish trend, supported by breakout patterns, rising volume, and momentum indicators. While RSI is in overbought territory, price action remains constructive. Traders may consider entering on minor dips with tight stop-losses and monitor for resistance near ₹3,875.

Want to compare this with other pharma stocks or overlay it with valuation metrics?

Edit in a page

Back to Technical List